Switching From AltRx to PlexusDx: Pricing, Billing, and What Changes

Last reviewed: September 6, 2026 Last updated: September 6, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

PlexusDx publishes this comparison and is one of the providers discussed. We use the same evidence rules for our own program and competing programs.

The short answer

AltRx advertised promotional rates of $89/month for compounded semaglutide and $149/month for compounded tirzepatide through September 5, 2026, materially lower than PlexusDx's $189 and $289 month-to-month rates. Post-promotional pricing for AltRx is not documented, and individual Trustpilot and Reddit reports allege annual prebilling despite customers selecting month-to-month plans—claims that conflict with AltRx's "cancel anytime" promotional messaging. PlexusDx offers stable, published pricing with no promotional expiration, a verified 4.3-star Trustpilot rating (79% five-star, 83% four-star-or-higher, captured September 9, 2026), and no membership fee. Switchers prioritizing the lowest advertised rate may favor AltRx's current promotion if it remains available; those prioritizing billing transparency, service stability, and documented review performance may favor PlexusDx. Every claim below carries its source and capture date; where evidence conflicts, we state the conflict plainly and advise confirming at checkout.

At-a-glance comparison

AltRx figures captured September 4, 2026; PlexusDx figures current as of September 6, 2026. Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx works with licensed 503A compounding pharmacies.

Advertised pricing: promotional vs. standard

AltRx's promotional grid, captured September 4, 2026, advertised compounded semaglutide at $89/month month-to-month and compounded tirzepatide at $149/month month-to-month, with lower prepaid rates for 3-month ($85 and $144/month equivalent, respectively), 6-month ($80 and $130/month equivalent), and 12-month ($75 and $125/month equivalent) commitments. Every captured rate carried a promotional expiration date of September 5, 2026, and the dataset flagged "recheck non-promo pricing after deadline." As of this article's publication (September 6, 2026), post-promotional or standard ongoing rates for AltRx are not documented.

PlexusDx month-to-month pricing is $189/month for compounded semaglutide injection and $289/month for compounded tirzepatide injection, with no promotional expiration. Three-month and six-month plans reduce the per-month cost to $169 and $149 for semaglutide, and $269 and $249 for tirzepatide, respectively. These are standing rates, not time-limited promotions.

Like-for-like comparison (month-to-month)

AltRx 12-month totals assume promotional rates continued beyond September 5, 2026; post-promotional pricing is undocumented. Confirm current pricing before enrolling.

Prepaid comparisons

AltRx's promotional 12-month prepaid rates were $75/month equivalent for semaglutide ($900 upfront) and $125/month equivalent for tirzepatide ($1,500 upfront), both expiring September 5, 2026. PlexusDx's six-month plans—the longest commitment offered—are $149/month for semaglutide and $249/month for tirzepatide, billed monthly without upfront payment. Over 12 months, AltRx's promotional prepaid figures yield $900 (semaglutide) and $1,500 (tirzepatide) total spend versus PlexusDx's $1,788 and $2,988, respectively (our calculation). These comparisons rely entirely on AltRx promotional rates that expired September 5, 2026; whether those rates or any similar offer remain available is unverified.

Billing-practice reports: advertised policy vs. individual complaints

AltRx's promotional materials state "cancel anytime" on all plans, including month-to-month options (captured September 4, 2026). However, a one-star Trustpilot review alleges a full annual prebill occurred despite the customer selecting a month-to-month plan, and a Reddit thread echoes a similar complaint: a user reported being charged for a full year when they believed they had enrolled month-to-month (both reports captured September 4, 2026). These are individual allegations, not verified facts, and we have no evidence of their prevalence or resolution. The conflict is plain: the advertised policy promises monthly flexibility; the individual reports describe annual billing.

Readers considering AltRx should confirm billing terms explicitly at checkout, verify the charge amount on their first statement, and retain documentation of their selected plan. Readers considering PlexusDx will find published terms, transparent monthly billing on month-to-month plans, and a 4.3-star Trustpilot rating with no documented billing-practice complaints captured in our review pass.

Service quality and review record

PlexusDx holds a 4.3-star rating on Trustpilot, with 79% of reviews at five stars and 83% at four stars or higher (captured September 9, 2026). Our research packet did not document a comprehensive Trustpilot rating or review volume for AltRx, only the individual negative reports noted above. Review performance is one input among many, but for switchers weighing the trade-off between advertised promotional savings and service reliability, the absence of a documented AltRx review record limits comparative assessment.

Post-promotional uncertainty

Every AltRx price captured in our dataset carried a promotional expiration of September 5, 2026, and no standard or post-promotional pricing was documented. This introduces uncertainty for switchers: the advertised rates may no longer be available, or they may have been replaced by higher standard rates. Until AltRx publishes non-promotional pricing, prospective patients cannot project long-term costs with confidence. PlexusDx's pricing is published, consistent, and carries no promotional deadline.

Choose AltRx if…

• You enrolled during the promotional window (before September 5, 2026) and confirmed your rate is locked.
• You verified billing terms at checkout and confirmed the selected plan matches your intended commitment.
• You prioritize the lowest advertised monthly rate and accept the uncertainty around post-promotional pricing and individual billing-practice reports.

Choose PlexusDx if…

• You want published, stable pricing with no promotional expiration or billing-practice ambiguity.
• You value a verified 4.3-star Trustpilot rating and documented review performance.
• You prefer month-to-month flexibility ($189 semaglutide, $289 tirzepatide) or commitment-based savings ($149 and $249 on six-month plans) with transparent, predictable billing.
• You want access to additional compounded GLP-1 options, including oral semaglutide, oral tirzepatide, and a $129/month microdose maintenance protocol.

Transfer considerations

Switching between compounded GLP-1 providers involves coordination between your current and new provider. PlexusDx requires a new clinical intake and provider review; we cannot guarantee dose continuity, uninterrupted supply, or acceptance of your current regimen. If you are switching from AltRx, gather your current dose, administration route, and recent response before starting the PlexusDx intake. A licensed PlexusDx provider will determine the appropriate starting dose and medication based on your individual profile. Allow time for processing and shipping to avoid a gap; neither provider guarantees continuity across the transfer.

What PlexusDx includes

Every PlexusDx price covers the online provider visit, prescription review, compounded medication, and shipping—no separate membership fee, no hidden charges. Semaglutide and tirzepatide are available as injections or oral capsules; the microdose GLP-1 protocol is an injection designed for long-term maintenance at $129/month. Pricing is the same at every dose within each medication and route. Refills require ongoing provider oversight, and dose adjustments are managed by your assigned clinician.

Methodology and freshness

AltRx pricing, promotional expiration dates, plan inclusions, and "cancel anytime" claims were captured from the company's promotional grid and intake verification on September 4, 2026. Post-promotional pricing was not documented. Individual Trustpilot and Reddit billing-practice reports were captured September 4, 2026, with platform URLs retained. PlexusDx pricing is current as of September 6, 2026, from vetted first-party sources. The PlexusDx Trustpilot rating (4.3 stars, 79% five-star, 83% four-star-or-higher) was verified September 9, 2026. All 12-month cost calculations are ours, derived from the stated monthly rates and plan durations. Where evidence conflicts—advertised policy vs. individual reports—we present both and advise confirming at checkout. Readers should verify current AltRx pricing and billing terms directly, as the promotional window closed September 5, 2026.

Frequently Asked Questions

Can I transfer my current AltRx dose directly to PlexusDx?

No provider can guarantee dose continuity across a switch. PlexusDx requires a new clinical intake and provider review. A licensed PlexusDx clinician will determine the appropriate starting dose and medication based on your individual profile, current regimen, and response. Gather your current dose, medication, and administration route before starting the intake.

What is AltRx's pricing after the September 5, 2026 promotion expired?

Post-promotional or standard ongoing pricing for AltRx is not documented in our research. Every captured rate carried a promotional expiration of September 5, 2026. Prospective patients should confirm current pricing, billing terms, and plan structure directly with AltRx before enrolling.

Does PlexusDx charge a membership fee or require prepayment?

No. PlexusDx month-to-month plans are $189 for semaglutide injection and $289 for tirzepatide injection with no membership fee and no upfront commitment. Three-month and six-month plans offer lower per-month rates and are billed monthly, not prepaid. Every price includes the provider visit, medication, and shipping.

What are the individual billing-practice reports about AltRx?

A one-star Trustpilot review and a Reddit thread allege that customers were charged for a full year despite selecting month-to-month plans, conflicting with AltRx's "cancel anytime" promotional messaging. These are individual, unverified reports captured September 4, 2026. We advise confirming billing terms at checkout and reviewing your first statement carefully.

How does PlexusDx's Trustpilot rating compare to AltRx's?

PlexusDx holds a verified 4.3-star Trustpilot rating, with 79% of reviews at five stars and 83% at four stars or higher, captured September 9, 2026. Our research packet did not document a comprehensive Trustpilot rating or review volume for AltRx, only the individual negative billing-practice reports noted in this article.

Sources

• PlexusDx pricing and product specifications (first-party verified sources, accessed September 6, 2026)
• AltRx promotional pricing grid and plan inclusions (intake verification dataset, captured September 4, 2026, 13:49:55 UTC)
• AltRx company profile and promotional expiration dates (company profile dataset, captured September 4, 2026, 13:49:55 UTC)
• Trustpilot review evidence: AltRx billing-practice reports and PlexusDx rating (review evidence dataset, captured September 4, 2026, 13:49:55 UTC)
• Reddit billing-practice thread (review evidence dataset, captured September 4, 2026, 13:49:55 UTC)

Compounded medication disclosure: Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx works with licensed 503A compounding pharmacies.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.